PRE-DRIVE C2X Deliverable D0.3 Final report_20100929.pdf

More documents

Recommendations

Info

Final Report PRE-DRIVE C2X 29.9.2010 Number & short description of foreground: How can the foreground be exploited, by when and by whom Which IPR exploitable measures are taken or intended Which further research is necessary, if any Which potential impact is expected (quantify where possible) 7: Adaptation of interfaces to include C2X functionalities in traffic simulation software (COM) The commercial traffic simulation software tool VISSIM was enhanced by adapting the interfaces to accommodate a coupling to communication simulation tools. This means that the value of the tool is enhanced. Such interfaces can readily be offered to costumers. n.a. None It is expected that the market strength of VISSIM is further improved. Deliverable D0.3 Version 1.0 113 Final Report
PRE-DRIVE C2X 29.09.2010 6 Report on societal implications 6.1.1 A: General information Grant Agreement Number: 224019 PREparation for DRIVing implementation and Evaluation Title of Project: of C2X communication technology Name and Title of Coordinator: Matthias Schulze, Senior Manager Driver Support and Warning 6.1.2 B: Ethics 1. Did your project undergo an Ethics Review and/or Screening)? * If Yes: have you described the progress of compliance wihtthe relevant Ethics Review/ Screening Requirements in the frame of the periodic/final project reports? Special Reminder: the progress of compliance with the Ethics Review/ Screening Requirements should be described in the Period/ Final Project Reports under the Section “Work Progress and Achievements” 2. Please indicate whether your project involved any of the following issues (tick box) : RESEARCH ON HUMANS Did the project involve children? Did the project involve patients? Did the project involve persons not able to give consent? Did the project involve adult healthy volunteers? Did the project involve Human Genetic Material? Did the project involve Human biological samples? Did the project involve Human data collection? RESEARCH ON HUMAN EMBRYO/FOETUS Did the project involve Human Embryos? Did the project involve Human Foetal Tissue / Cells? Did the project involve Human Embryonic Stem Cells (hESCs)? Did the project on human Embryonic Stem Cells involve cells in culture? Did the project on human embryonic Stem Cells involve the derivation of cells from Embryos? PRIVACY Did the project involve processing of genetic information or personal data (eg. health, sexual lifestyle, ethnicity, political opinion, religious or philosophical conviction) Did the project involve tracking the location or observation of people? RESEARCH ON ANIMALS Did the project involve research on animals? Were those animals transgenic small laboratory animals? Were those animals transgenic farm animals? Were those animals cloned farm animals? Were those animals non-human primates? RESEARCH INVOLVING DEVELOPING COUNTRIES Did the project involve the use of local resources (genetic, animal, plant etc.) ◦ Yes x No No No No No No No No No No No No No No No No No No No No YES Deliverable D0.3 Version 1.0 114 Final Report
Page 1 and 2:
Deliverable D0.3 Final Report Versi
Page 3 and 4:
Legal disclaimer PRE-DRIVE C2X 9/29
Page 5 and 6:
PRE-DRIVE C2X 9/29/2010 Table of co
Page 7 and 8:
PRE-DRIVE C2X 9/29/2010 1 Managemen
Page 9 and 10:
PRE-DRIVE C2X 9/29/2010 With the po
Page 11 and 12:
PRE-DRIVE C2X 9/29/2010 2.1.5 WP500
Page 13 and 14:
Final Report PRE-DRIVE C2X 29.9.201
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74: Final Report PRE-DRIVE C2X 29.9.201
Page 123: Final Report PRE-DRIVE C2X 29.9.201
Page 127 and 128: PRE-DRIVE C2X 29.09.2010 6.1.5 E: S
Page 129 and 130: PRE-DRIVE C2X 29.09.2010 6.1.8 H: U
Page 131: PRE-DRIVE C2X 29.09.2010 3. MEDICAL
show all

PRE-DRIVE C2X Deliverable D0.3 Final report_20100929.pdf

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?